Peptide Registry

Vials

Capsules

Liquids

a capsule of BAM 15

BAM15

$169.00

  • Contents: BAM15 (N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine; mitochondrial protonophore)
  • Format: Encapsulated solid
  • Appearance: White to off-white solid
  • Purity: >99%
Quantity Discount Price
1 - 3 - $169.00
4 - 7 10% $152.10
8 + 18% $138.58
SKU: N/A Category: Brand:

Description

BAM15 capsules provide the selective mitochondrial protonophore uncoupler BAM15 in a pre-weighed 50mg encapsulated format. As a lipophilic small molecule with documented oral bioavailability in preclinical models, BAM15 is suited to a capsule format for oral administration research protocols examining mitochondrial uncoupling, proton gradient dissipation, and oxidative phosphorylation biology.

Storage and Handling

Store in a cool, dry place away from heat, moisture, and direct light. Keep container tightly sealed when not in use. BAM15 is stable under standard ambient storage conditions for short-term use; refer to the lot-specific certificate of analysis for recommended conditions. For analytical use requiring dissolved compound, remove capsule contents and dissolve in an appropriate laboratory solvent such as DMSO.

Compliance Notice

BAM15 capsules are supplied for laboratory research use only. They are not intended for human or veterinary use and carry no therapeutic, diagnostic, or clinical indication. This product has not been evaluated by the FDA. By purchasing this product, the buyer confirms it will be used exclusively for controlled research by qualified personnel following appropriate institutional safety procedures.

Frequently Asked Questions

How does the capsule format differ from the powder format for BAM15 research?

The capsule format provides pre-weighed 50mg doses without requiring individual weighing from bulk material. Researchers designing oral gavage or oral bioavailability studies in preclinical models may find the encapsulated format more practical. For in vitro cell-based assays requiring dissolved compound at precise concentrations in DMSO or aqueous buffer, capsule contents should be removed and dissolved independently. The powder format remains appropriate for protocols requiring custom concentrations.

Why is BAM15 suited to oral capsule format in research models?

BAM15 is a lipophilic small molecule with documented oral bioavailability in preclinical studies. Its chemical structure enables absorption through the gastrointestinal tract intact, making oral administration a valid experimental condition for studying mitochondrial uncoupling effects following enteral delivery. This distinguishes it from larger peptide compounds where oral bioavailability is limited by gastric degradation.

Related products